Open access
114
Views
11
CrossRef citations to date
0
Altmetric
Review
Use of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomes
Guy JerusalemMedical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, BelgiumCorrespondence[email protected]
, Andree RoriveMedical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium
& Joelle CollignonMedical Oncology, CHU Sart Tilman Liege, Domaine Universitaire du Sart Tilman, Liege, Belgium
Pages 43-57
|
Published online: 17 Apr 2014
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.